LSV ASSET MANAGEMENT - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 51 filers reported holding PSYCHEMEDICS CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LSV ASSET MANAGEMENT ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q4 2018$531,000
-31.6%
33,508
-18.8%
0.00%0.0%
Q3 2018$776,000
-9.7%
41,287
-7.6%
0.00%0.0%
Q2 2018$859,000
-7.0%
44,6880.0%0.00%0.0%
Q1 2018$924,000
-0.8%
44,688
-1.3%
0.00%0.0%
Q4 2017$931,000
+64.8%
45,288
+47.6%
0.00%0.0%
Q3 2017$565,000
-14.1%
30,688
+16.2%
0.00%0.0%
Q2 2017$658,000
+265.6%
26,404
+193.4%
0.00%
Q1 2017$180,0009,0000.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2017
NameSharesValueWeighting ↓
22NW, LP 274,418$1,089,4390.78%
WEALTH EFFECTS LLC 40,701$161,5820.08%
Cannell Capital 74,794$296,9320.07%
SANTA MONICA PARTNERS LP 20,000$790.06%
RBF Capital, LLC 144,231$572,5970.04%
WEDBUSH SECURITIES INC 42,414$1680.01%
Ancora Advisors LLC 78,373$311,1410.01%
Your Advocates Ltd., LLP 1,400$5,5580.00%
CRAWFORD INVESTMENT COUNSEL INC 32,098$127,4280.00%
Renaissance Technologies 273,663$1,0860.00%
View complete list of PSYCHEMEDICS CORP shareholders